[1] Ferlin G, Borsato N, Camerani M, et al.  New perspectives in localizing enlarged parathyroids by technetium-thallium subtraction scan[J]. J Nucl Med, 1983, 24(5): 438-441.
[2] Basso LV, Keeling C, Goris ML.  Parathyroid imaging[J]. Use of dual isotope scintigraphy for the localization of adenoma before surgery. Clin Nucl Med, 1992, 17(5): 380-383.
[3] Hauty M, Swartz K, McClung M, et al.  Technetium-thallium scintiscanning for localization of parathyroid adenomas and hyperplasia[J]. A reappraisal. Am J Surg, 1987, 153(5): 479-486.   doi: 10.1016/0002-9610(87)90798-7
[4] Coakley AJ, Kettle AG, Wells CP, et al.  99mTc-sestamibi-a new agent forparathyroid imaging[J]. NuclMedCommun, 1989, 10(11): 791-794.
[5] Melloul M, Paz A, Koren R, et al.  99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance[J]. Eur J Nucl Med, 2001, 28(2): 209-213.   doi: 10.1007/s002590000406
[6] Tomas MB, Pugliese PV, Tronco GG, et al.  Pinhole versus parallelhole collimators for parathyroid imaging: an intraindividual comparison[J]. J Nucl Med Technol, 2008, 36(4): 189-194.   doi: 10.2967/jnmt.108.055640
[7] De Feo ML, Colagrande S, Biagini C, et al.  Parathyroid glands combination of 99mTc-MIBI scintigraphy and US for demonstration of parathyroid glands and nodules[J]. Radiology, 2000, 214(2): 393-402.   doi: 10.1148/radiology.214.2.r00fe04393
[8] Hindié E, Mellière D, Jeanguillaume C, et al.  Parathyroid imaging using simultaneous double-window recording of technetium-99msestamibi and iodine-123[J]. J NucI Med, 1998, 39(6): 1100-1105.
[9] Chen CC, Holder LE, Scovill WA, et al.  Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT[J]. J Nucl Med, 1997, 38(6): 834-839.
[10] Palestro CJ, Tomas MB, Tronco GG.  Radionuclide imaging of the parathyroid glands[J]. Semin Nucl Med, 2005, 35(4): 266-276.   doi: 10.1053/j.semnuclmed.2005.06.001
[11] Billotey C, Sarfati E, Aurengo A, et al.  Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy[J]. J Nucl Med, 1996, 37(11): 1773-1778.
[12] Gayed IW, KimEE, BroussardWF, etal.  The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia[J]. J Nucl Med, 2005, 46(2): 248-252.
[13] Neumann DR, Obuchowski NA, Difilippo FP.  Preoperative 123I/ 99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism[J]. J Nucl Med, 2008, 49(12): 2012-2017.   doi: 10.2967/jnumed.108.054858
[14] Ishibashi M, Nishida H, Kumabe T, et al.  Tc-99m tetrofosmin[J]. A new diagnostic tracer for parathyroid imaging. Clin Nucl Med, 1995, 20(10): 902-905.
[15] Hiromatsu Y, Ishibashi M, Nishida H, et al.  Technetium-99m tetrofosmin parathyroid imaging in patients with primary hyperparathyroidism[J]. Intern Med, 2000, 39(2): 101-106.   doi: 10.2169/internalmedicine.39.101
[16] Fjeld JG, Erichsen K, Pfeffer PF, et al.  Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi[J]. J Nucl Med, 1997, 38(6): 831-834.
[17] Sundin A, Johansson C, Hellman P, et al.  PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism[J]. J Nucl Med, 1996, 37(11): 1766-1770.
[18] Beggs AD, Hain SF.  Localization of parathyroid adenomas of using 11C-methionine positron emission tomography[J]. Nucl Med Commun, 2005, 26(2): 133-136.   doi: 10.1097/00006231-200502000-00009
[19] Otto D, Boerner AR, Hofmann M, et al.  Pre-operative localization of hyperfunctional parathyroid tissue with 11C-methionine PET[J]. Eur J Nucl Med Mol Imaging, 2004, 31(10): 1405-1412.
[20] Weber T, Cammerer G, Schick C, et al.  C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism[J]. Horm Metab Res, 2010, 42(3): 209-214.   doi: 10.1055/s-0029-1243185
[21] Bahar G, Feinmesser R, Joshua BZ, et al.  Hyperfunctioning intrathyroid parathyroid gland: a potential cause of failure in parathy-roidectomy[J]. Surgery, 2006, 139(6): 821-826.   doi: 10.1016/j.surg.2005.11.009
[22] Piga M, Bolasco P, Satta L, et al.  Double phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism[J]. J Nucl Med, 1996, 37(4): 565-569.
[23] Takeuchi H, Greep NC, Hoon DS, et al.  Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary hyperparathyroidism and its effect on sestamibi imaging[J]. J Clin Endocrinol Metab, 2007, 92(5): 1785-1790.   doi: 10.1210/jc.2006-2010
[24] Nichols KJ, Tomas MB, Tronco GG, et al.  Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings[J]. Radiology, 2008, 248(1): 221-232.   doi: 10.1148/radiol.2481071066
[25] Mihai R, Gleeson F, Buley ID, et al.  Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients[J]. World J Surg, 2006, 30(5): 697-704.   doi: 10.1007/s00268-005-0338-9
[26] Torregrosa JV, Fernández-Cruz L, Canalejo A, et al.  99mTc-sestamibi scintigraphyandcell cycle in parathyroid glands of secondary hyper-parathyroidism[J]. World J Surg, 2000, 24(11): 1386-1390.   doi: 10.1007/s002680010229
[27] Kao A, Shiau YC, Tsai SC, et al.  Technetium-99m methoxyisobutilisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression[J]. Eur J Nucl Med Mol Imaging, 2002, 29(8): 1012-1015.   doi: 10.1007/s00259-002-0817-2
[28] Yamaguchi S, Yachiku S, Hashimoto H, et al.  Relation between technetium-99m methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands[J]. World J Surg, 2002, 26(1): 29-34.   doi: 10.1007/s00268-001-0177-2
[29] Shiau YC, Tsai SC, Wang JJ, et al.  Detecting parathyroid adenoma using technetium-99m tetrofosimin: comparison with P-glycoprotein and multidrug resistance related protein expression—a preliminary report[J]. Nucl Med Biol, 2002, 29(3): 339-344.   doi: 10.1016/S0969-8051(01)00314-6
[30] Huang WT.  Size and P-glycoprotein expression limit 99mTc-tetrofosmin uptake in parathyroid adenomas[J]. Nucl Med Commun, 2002, 23(10): 1001-1004.   doi: 10.1097/00006231-200210000-00010
[31] Fuster D, Ybarra J, Torregrosa JV, et al.  Double-phase parathyroid 99mTc-sestamibi scintigraphy in chronic haemodialysis patients: correlation with biochemical markers of parathyroid function[J]. Nucl Med Commun, 2003, 24(1): 85-90.   doi: 10.1097/00006231-200301000-00019